BR9305995A - Peptideo para diagnosticar imunizar contra infecçao por T. Cruzi ensaio de diagnóstico Elisa para detectar anticorpos especificos da infecçao por T. Cruzi no sangue método de detecçao da doença de chagas ou infecçao por T. Cruzi e vacina para imunizar um individuo contra a doença de chagas - Google Patents

Peptideo para diagnosticar imunizar contra infecçao por T. Cruzi ensaio de diagnóstico Elisa para detectar anticorpos especificos da infecçao por T. Cruzi no sangue método de detecçao da doença de chagas ou infecçao por T. Cruzi e vacina para imunizar um individuo contra a doença de chagas

Info

Publication number
BR9305995A
BR9305995A BR9305995A BR9305995A BR9305995A BR 9305995 A BR9305995 A BR 9305995A BR 9305995 A BR9305995 A BR 9305995A BR 9305995 A BR9305995 A BR 9305995A BR 9305995 A BR9305995 A BR 9305995A
Authority
BR
Brazil
Prior art keywords
cruzi infection
immunize
chagas disease
diagnose
vaccine
Prior art date
Application number
BR9305995A
Other languages
English (en)
Inventor
Steven G Reed
Original Assignee
Iasys Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iasys Corp filed Critical Iasys Corp
Publication of BR9305995A publication Critical patent/BR9305995A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9305995A 1992-02-14 1993-02-11 Peptideo para diagnosticar imunizar contra infecçao por T. Cruzi ensaio de diagnóstico Elisa para detectar anticorpos especificos da infecçao por T. Cruzi no sangue método de detecçao da doença de chagas ou infecçao por T. Cruzi e vacina para imunizar um individuo contra a doença de chagas BR9305995A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/836,642 US5304371A (en) 1992-02-14 1992-02-14 Peptide for diagnosing and immunizing against T. cruzi infection
PCT/US1993/001231 WO1993016199A1 (en) 1992-02-14 1993-02-11 PEPTIDE FOR DIAGNOSING AND IMMUNIZING AGAINST T. cruzi INFECTION

Publications (1)

Publication Number Publication Date
BR9305995A true BR9305995A (pt) 1997-03-11

Family

ID=25272399

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9305995A BR9305995A (pt) 1992-02-14 1993-02-11 Peptideo para diagnosticar imunizar contra infecçao por T. Cruzi ensaio de diagnóstico Elisa para detectar anticorpos especificos da infecçao por T. Cruzi no sangue método de detecçao da doença de chagas ou infecçao por T. Cruzi e vacina para imunizar um individuo contra a doença de chagas

Country Status (8)

Country Link
US (2) US5304371A (pt)
EP (1) EP0649475B1 (pt)
BR (1) BR9305995A (pt)
CA (1) CA2129747C (pt)
DE (1) DE69319909D1 (pt)
ES (1) ES2118939T3 (pt)
MX (1) MX9300787A (pt)
WO (1) WO1993016199A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876734A (en) 1994-03-24 1999-03-02 Kirchhoff; Louis V. Polypeptides for diagnosing infection with Trypanosoma cruzi
US6013268A (en) 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US5879687A (en) * 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
JP3556228B2 (ja) * 1994-07-25 2004-08-18 ロシュ ダイアグノスティックス ゲーエムベーハー 複数の抗原を使用した特異的免疫グロブリンの測定
US5756662A (en) * 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
US5912166A (en) * 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US6419933B1 (en) * 1995-11-14 2002-07-16 Corixa Corporation Compounds and methods for the detection and prevention of T.cruzi infection
US5916572A (en) * 1995-11-14 1999-06-29 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6054135A (en) * 1996-11-14 2000-04-25 Corixa Compounds and methods for the detection and prevention of T. cruzi infection
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US6134846A (en) * 1997-11-18 2000-10-24 Lamb; Charles Modular slatwall system
US6875584B1 (en) 1999-03-02 2005-04-05 University Of Georgia Research Foundation, Inc. Prophylactic and therapeutic immunization against protozoan infection and disease
AR027370A1 (es) * 2000-02-17 2003-03-26 Lg Chemical Ltd Inmunoensayo y reactivo de diagnostico para malaria, y correspondientes metodos de preparacion, vectores de expresion y transformantes
US9028844B2 (en) 2006-03-17 2015-05-12 Vib Vzw Vaccine against Trypanosoma cruzi infection
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
WO2010003085A1 (en) 2008-07-03 2010-01-07 Infectious Disease Research Institute Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
WO2023114960A1 (en) * 2021-12-17 2023-06-22 The Administrators Of The Tulane Educational Fund Antigenic peptides and methods of use for diagnosis of chagas disease

Also Published As

Publication number Publication date
EP0649475A4 (en) 1995-12-20
DE69319909D1 (de) 1998-08-27
MX9300787A (es) 1993-11-01
ES2118939T3 (es) 1998-10-01
WO1993016199A1 (en) 1993-08-19
US5304371A (en) 1994-04-19
EP0649475B1 (en) 1998-07-22
US5413912A (en) 1995-05-09
CA2129747C (en) 2001-04-17
CA2129747A1 (en) 1993-08-15
EP0649475A1 (en) 1995-04-26

Similar Documents

Publication Publication Date Title
BR9305995A (pt) Peptideo para diagnosticar imunizar contra infecçao por T. Cruzi ensaio de diagnóstico Elisa para detectar anticorpos especificos da infecçao por T. Cruzi no sangue método de detecçao da doença de chagas ou infecçao por T. Cruzi e vacina para imunizar um individuo contra a doença de chagas
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
HUP0203705A2 (hu) Vegyületek és eljárások Chlamydia-fertőzés kezelésére és diagnózisára
WO1998042740A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
NO20012812D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av chlamydiainfeksjon
WO1996003502A3 (en) Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer
FR2652004B1 (fr) Nouveaux derives hydrophiles, application au diagnostic et a la therapeutique, kits diagnostiques ou therapeutiques et reactifs immunologiques.
DE3781610D1 (de) Diagnostikum fuer lyme-krankheit.
FR2766192B1 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
NO873495D0 (no) Monoklonale antistoffer og peptider egnet for behandling og diagnose av hiv-infeksjoner.
WO2000000615A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
PT89107A (pt) Metodo e meios para a seleccao de anticorpos anti-idiotipos e seu uso para o diagnostico, monitorizacao, tratamento e/ou prevencao de doencas cancerosas, da autoimunidade ou infecciosas
ES2078733T3 (es) Metodo para la deteccion de anticuerpos anti-arn.
DE68917035D1 (de) Doppler-Ultraschallgerät zur Bestimmung von Blutströmungsgeschwindigkeiten.
DE68922595D1 (de) Doppler-Ultraschallgerät zur Bestimmung von Blutströmungsgeschwindigkeiten.
HU906639D0 (en) Diagnostic process for detecting htlv-i peptides and their antibodies causing infection, and vaccine for treating the disease
BR9611455A (pt) Compostos e métodos para a detecção e prevenção de infecção por t. cruzi.
EP0834567A3 (en) Compounds and methods for the diagnosis and treatment of Babesia microti infection
FR2608767B1 (fr) Procede pour la detection et le dosage des anticorps anti-(sporozoaires de p. falciparum) dans le sang humain et trousses de diagnostic pour mettre en oeuvre ce procede
Welsh et al. Sporothnx Whole Yeast Agglutination Test: Low-titer Reactions of Sera of Subjects Not Known to Have Sporotrichosis
FR2757864B1 (fr) Anticorps reconnaissant specifiquement une proteine nitrosylee, leur procede de preparation, leur utilisation therapeutique et diagnostique
DE69535156D1 (de) Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion
WO1999001085A3 (en) Autoimmune inner ear disease antigen and diagnostic assay
Zabriskie et al. The role of heart binding antibodies in rheumatic fever

Legal Events

Date Code Title Description
EE Request for examination
FA Application withdrawn
B15K Others concerning applications: alteration of classification

Ipc: C07K 14/44 (2006.01), A61K 39/39 (2006.0